COVID Vaccination in DMT-Treated MS Patients: New Data Uncategorized / June 21, 2022 COVID rates after vaccination are relatively low and cases mild in patients with multiple sclerosis treated with disease-modifying therapies – but vaccine antibody response is lower with anti-CD20 therapies. Medscape Medical News